PSORIATIC ARTHRITIS (PSA) is a chronic inflammatory disease characterized by joint pain, stiffness, and swelling and clinically presents as axial or peripheral arthritis, dactylitis, and nail or skin lesions. Usually PsA occurs after the development of psoriasis. However, in a small number of patients, joint problems begin before psoriasis appears.1
More than 8 million Americans live with psoriasis, and PsA affects between 15% and 30% of those individuals.2 The disease also affects men and women almost equally, with a peak onset age between 40 and 50 years, although it can begin at any time.1,3 A hereditary link also appears evident, as individuals who have a first-degree relative with the condition have a 40% greater chance of developing the disease.4
Effective and timely treatment is important in PsA because the earlier it is diagnosed, the sooner treatment can begin, thus slowing down permanent joint and tissue damage and the progression of disability.1 However, diagnosis is often delayed because of the generality of symptoms, and study results show that just 30% of patients receive a proper diagnosis within the first 6 months of symptom onset.5,6
Although the number of drugs for PsA has increased over the past decade, half of treated patients still do not achieve optimal outcomes, and little guidance exists to help practitioners with medication choice. Physicians make their decisions based on the clinical disease domain affected, cost, and provider familiarity.7
Considerations and Goals of Therapy No cure for PsA exists, so the goals of treatment are to slow disease progression, improve quality of life, lessen pain, and preserve range of motion. With variable presentation and 5 subtypes of disease, practitioners must assess the clinical presentations and locations affected and choose therapy accordingly.6,7
Therapeutic treatment is usually focused on a particular goal, with minimal disease activity (MDA) criteria recommended as the treatment target in patients with PsA. Evidence shows that patients who meet those criteria have better quality of life, less joint damage, and more functional ability.7 Practitioners also need to consider comorbidities because patients suffering from PsA are more likely to have cardiovascular disease, metabolic syndrome, depression, and diabetes.1,4
Treatment Selection and Strategies In most patients with PsA, pharmacological treatment consists of a trial-and-error approach, beginning with corticosteroids and nonsteroidal anti-inflammatory drugs to manage symptoms. Physicians often use conventional synthetic disease-modifying antirheumatic drugs (DMARDs), followed by biological DMARDs if a patient does not adequately respond.1,2 However, the American College of Rheumatology (ACR) and the National Psoriasis Foundation have challenged this historical approach, instead recommending biological DMARDs as first-line therapy.2,3,7,8
Biological therapy has 5 mechanisms, with tumor necrosis factor (TNF) inhibitors the most established. Patients often receive these as first-line therapy because of more robust outcome data, physician familiarity, and lower costs due to TNF biosimilars. Interleukin (IL-17A, IL-12, and IL-23) inhibitors tar get disease-specific cytokines. Oral small molecules include Janus kinase inhibitors that block the downstream signal of multiple cytokine receptors and a PDE4 inhibitor that blocks the degradation of cyclic adenosine monophosphate in immune cells, thus inhibiting an inflammatory response.7,9
A preferred hierarchy of drug selection has not been established, and because of the clinical heterogeneity of PsA, large studies need to evaluate the different clinical domains of the diseases. To date, only 1 large head-to-head study has compared biologics for PsA. In that study, Mease et al compared the IL-7 inhibitor ixekizumab with adalimumab, and results showed the superiority of ixekizumab in the primary outcome of patients achieving ACR50 criteria and 100% reduction in the Psoriasis Area and Severity Index.10 The study results also showed noninferiority to adalimumab.10
Physicians have no way to predict who will and will not respond to therapies, and because biological and targeted synthetic DMARD treatment usually lasts for 12 to 24 weeks, a longer period of suboptimal therapy may result.2,3 These delays can also contribute to both negative outcomes and decreased quality of life.
Future DirectionThe approach of using biologics in patients with PsA without an evidence-based stratification or personalization tool has led to more than 50% of patients not meeting their therapeutic target as defined by the MDA criteria. Some patients who have failed prior first-line biological therapy may have a response when they switch to a drug with a different mechanism of action, which may suggest that disease pathogenesis can differ among individuals.7,11
In 2019, the first study addressing precision medicine in PsA was published. Miyagawa and colleagues conducted the trial and looked at evaluating baseline CD4 T-cell activation markers to select appropriate therapy for patients with PsA.12 Even though the trial had limitations, the results were promising, and it was the first study to use baseline immunophenotyping when selecting therapy.7,12
Personalized treatment selection has had success in other autoimmune disease states, such as rheumatoid arthritis. In the future, a combination of immunophenotyping and statistical analyses could assist in a targeted treatment approach that has the potential to maximize outcomes in patients with PsA without delay.7
What Pharmacists Should Know Many effective DMARDs are available. However, patients respond differently and may not achieve optimal outcomes with their first choice of treatment, which contributes to delays and poorer long-term results. Practitioners should base treatment selection on clinical areas involved, comorbidities, and evidence. Many biologics also have specialty distribution pathways, which can present a challenge to patients who must navigate the system.
Although new treatment selections offer opportunities for therapy, they also present new challenges, and pharmacists must be knowledgeable about evidence-based studies that can help guide and individualize treatment for PsA.
REFERENCES
Go here to see the original:
What Is the Future of Psoriatic Arthritis Treatment? - Pharmacy Times
- Team USA diver from The Woodlands fights juvenile arthritis - FOX 26 Houston - May 5th, 2024
- The best products for arthritis in hands 2024 - National Geographic - May 5th, 2024
- Analysis Strongly Supports Turmeric Supplementation to Improve Arthritis and Osteopenia - Good News Network - May 5th, 2024
- May is arthritis awareness month - SSM Health - May 5th, 2024
- Lower CVD Risk With Stable DMARD Therapy in Seropositive RA - Medscape - May 5th, 2024
- Arthritis Pain: Which Vitamins and Minerals Are Best? - Shape Magazine - May 5th, 2024
- Psoriatic Arthritis Triggers: Stress, Illness, Weather and More - Health Central - May 5th, 2024
- Arthritis Foundation Partners with Target to Produce Ease of Use Design Guides for Product and Packaging Design - AccessWire - May 5th, 2024
- MSPCA seeks donations to help offset cost of surgery for German shepherd with severe arthritis - Boston News ... - Boston News, Weather, Sports | WHDH... - May 5th, 2024
- Team USA diver from The Woodlands fights juvenile arthritis - FOX 5 Atlanta - May 5th, 2024
- May 18: It's time to Walk to Cure Arthritis - Manchester Ink Link - May 5th, 2024
- Cracking Knuckles Causes Arthritis And Other Common Myths Debunked - Onlymyhealth - May 5th, 2024
- Fast Five Quiz: The Role of Joint Replacement Surgery in PsA - Page 2 - Medscape Reference - May 5th, 2024
- Arthritic Therapeutic Market Poised to Surpass $136.1+ Billion Globally by 2032, Fueled by a 5.5% CA - PharmiWeb.com - May 5th, 2024
- Pharmacist explains best diet to reduce arthritis, inflammation and joint pain - The Mirror - March 10th, 2024
- Teen Raises Funds to Fight Arthritis - Arthritis Foundation - March 10th, 2024
- Is there a higher risk of depression among specific populations of patients with rheumatoid arthritis? - News-Medical.Net - March 10th, 2024
- Here's How to Explain Your Arthritis Pain to Your Doctor So They Actually Get It - Northwest Georgia News - March 10th, 2024
- Despite Their Prevalence, Arthritis, Neck and Back Pain Receive Few Research Dollars, Analysis Finds | BIDMC of ... - Beth Israel Deaconess Medical... - March 10th, 2024
- This Is the Difference Between Rheumatoid and Psoriatic Arthritis - Prescott Daily Courier - March 10th, 2024
- The #1 Early Sign of Arthritis Most People Miss, According to a Rheumatologist - Northwest Georgia News - March 10th, 2024
- The Efficacy and Safety of Apremilast in the Management of Psoriatic Arthritis: A Systematic Review and Meta-Analysis - Cureus - March 10th, 2024
- MU Researchers Participating in International Clinical Study Targeting Prevention of Osteoarthritis - University of Missouri School of Medicine - March 10th, 2024
- Review: Real-World Evidence Confirms Effectiveness and Safety of Adalimumab Biosimilar SB5 - The Center for Biosimilars - March 10th, 2024
- A Gender-Bias-Mitigated, Data-Driven Precision Medicine System to Assist in the Selection of Biological Treatments of ... - Cureus - March 10th, 2024
- Young arthritis cases are on the rise, new research suggests - The Examiner - March 10th, 2024
- Quiz: ACR Guideline for the Treatment of Psoriatic Arthritis - MD Magazine - February 10th, 2024
- Psoriatic arthritis: What to know about medications for children - Medical News Today - February 10th, 2024
- Ancient Egyptian woman had holes on her bones. Experts say its rare case of disease - Miami Herald - February 10th, 2024
- Arthritis and Pregnancy: Fertility, Gestation, Postpartum - Verywell Health - February 10th, 2024
- 3500-year-old burial of Nubian woman reveals 1 of world's earliest known cases of rheumatoid arthritis - Livescience.com - February 10th, 2024
- Impact of frailty severity and severe pain on cognitive function for community-dwelling older adults with arthritis: a cross ... - Nature.com - February 10th, 2024
- IHL-675A: Advancing Towards Innovative Arthritis Solutions, with Mark Bleackley, PhD - MD Magazine - February 10th, 2024
- Insomnia, Shorter Sleep Duration Linked to the Risk of Autoimmune Arthritis - MD Magazine - February 10th, 2024
- Advancements in Psoriatic Arthritis Treatment for Children: A Beacon of Hope - Medriva - February 10th, 2024
- Breakthrough Molecule RvT4 Reverses Inflammation and Clears Arterial Blockages in Rheumatoid Arthritis Patients - SciTechDaily - February 10th, 2024
- Personal Experience with Psoriatic Arthritis and Atopic Dermatitis - Medriva - February 10th, 2024
- EULAR Recommendations on Imaging in Crystal-Induced Arthropathies (CiA) - Medriva - February 10th, 2024
- The Importance of Ultrasound-Guided Synovial Biopsy in the Workup of Seronegative Inflammatory Arthritis: A Case ... - Cureus - February 10th, 2024
- Autoimmune diseases like lupus, MS, and rheumatoid arthritis strike far more women than men. Scientists now think they know why - Fortune - February 2nd, 2024
- Multiple Ulcers in the Ileum and Lymphadenopathy Following the Usage of Methotrexate in a Patient With Rheumatoid ... - Cureus - February 2nd, 2024
- These are the best arthritis creams of 2024, according to health experts - Yahoo Life - February 2nd, 2024
- Do Your Joints Ache When a Storm Is Brewing? Here's What's Really Happening - DISCOVER Magazine - February 2nd, 2024
- Olympic bronze medalist opens up about balancing arthritis with motherhood and triathlon - TRI247 - February 2nd, 2024
- Some Dinosaurs May Have Had Arthritis 90 Million Years Ago - IFLScience - February 2nd, 2024
- 3500-year-old remains of ancient Egyptian suffering from rheumatoid arthritis uncovered - Xinhua - February 2nd, 2024
- Lupus and other autoimmune diseases strike far more women than men. Now there's a clue why - The Associated Press - February 2nd, 2024
- Rheumatoid Arthritis Awareness Day on February 2: What you need to know - CNBCTV18 - February 2nd, 2024
- Rheumatoid Arthritis Awareness Day 2024: Signs, Symptoms, Diagnosis, and Prevention - News18 - February 2nd, 2024
- Improving arthritis in cold weather | Health Smart - WPMT FOX 43 - February 2nd, 2024
- Rheumatoid Arthritis Awareness Day: History, Significance And All You Need To Know - ABP Live - February 2nd, 2024
- Dietary Factors Tied to Osteoarthritis Pain | MedPage Today - Medpage Today - February 2nd, 2024
- Cold-weather coping tips for people with arthritis, osteoporosis and lung diseases - Southernminn.com - February 2nd, 2024
- How to manage arthritis and joint pain: Effective tips for knee pain relief - Health shots - February 2nd, 2024
- New study illuminates the genetics of thumb arthritis treatment - News-Medical.Net - January 25th, 2024
- Rheumatoid arthritis: 30 minutes of walking may lower blood pressure - Medical News Today - January 25th, 2024
- RA Disease Activity Assessed Too Little After Starting TNFi - Medscape - January 25th, 2024
- Lifestyle tips for youth's bone health: Avoid these habits to prevent arthritis - Hindustan Times - January 25th, 2024
- Best arthritis pain relief cream of 2024, according to experts - AOL - January 25th, 2024
- Vasculitis, an Early Unusual Presentation of Rheumatoid Arthritis: A Case Report - Cureus - January 25th, 2024
- Patients with later menarche, earlier menopause have higher risk for rheumatoid arthritis - Healio - January 25th, 2024
- Investigating Maternal Inflammatory Arthritis and Pregnancy Outcomes < Yale School of Medicine - Yale School of Medicine - January 25th, 2024
- Rheumatoid Arthritis and Diabetes: What's the Connection? - Health Central - January 25th, 2024
- Oxidative DNA Damage and Zinc Status in Patients With Rheumatoid Arthritis in Duhok, Iraq - Cureus - January 25th, 2024
- Changes Afoot for the Treatment of Psoriatic Arthritis with Marked Gains in Preference and Utilization of IL-17 Inhibitors - Yahoo Finance - January 25th, 2024
- The Connection Between Potassium and Rheumatoid Arthritis - Health Central - January 25th, 2024
- What Is the ACR20 (American College of Rheumatology) Criteria? - Health Central - January 25th, 2024
- RA Treatment Advances and Where They Are Headed - Health Central - January 25th, 2024
- TMC Medical Minutes- Arthritis & Cold Weather - KXII - January 25th, 2024
- How to deal with joint and arthritis pain in the cold weather - Crossroads Today - January 25th, 2024
- Arthritis: Regular exercises, calcium-rich diet and other habits to keep your bones strong and healthy - Moneycontrol - January 25th, 2024
- Men With Arthritis Have Higher Fertility Rates, Study Finds - Zenger.News - January 25th, 2024
- Pain on Top of Foot: 5 Causes, Swelling, Treatment - Verywell Health - January 25th, 2024
- Understanding Rheumatoid Arthritis in Women: Genetics, Hormones, and Impact - Medriva - January 25th, 2024
- Arthritis | Johns Hopkins Medicine - January 9th, 2024
- Ideal cardiovascular health metrics have better identification of arthritis - BMC Public Health - BMC Public Health - January 9th, 2024
- Acupuncture for Arthritis: Benefits and Risks - Verywell Health - January 9th, 2024
- Why do arthritic horses have more trouble during the winter? - EQUUS Magazine - January 9th, 2024
- Rather than roll over and die, I'm like, 'No, I still want to play': Steve Morse says arthritis diagnosis forced him to ... - Guitar.com - January 9th, 2024
- Top Signs that Your RA Treatment May No Longer Be Working - Health Central - January 9th, 2024